{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:08:30Z","timestamp":1767154110967,"version":"build-2238731810"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fonds \"Ga\u00ebtan Lagneaux\""}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,4,12]]},"DOI":"10.1038\/s41416-021-01280-6","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T12:53:28Z","timestamp":1613566408000},"page":"1461-1462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comment on: \u201cPathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project\u201d"],"prefix":"10.1038","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-928X","authenticated-orcid":false,"given":"Mieke R.","family":"Van Bockstal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Libbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Galant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"1280_CR1","doi-asserted-by":"publisher","unstructured":"Shaaban, A. M., Hilton, B., Clements, K., Provenzano, E., Cheung, S., Wallis, M. G. et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer, https:\/\/doi.org\/10.1038\/s41416-020-01152-5 (2020).","DOI":"10.1038\/s41416-020-01152-5"},{"key":"1280_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","volume":"243","author":"N Portolani","year":"2006","unstructured":"Portolani, N., Coniglio, A., Ghidoni, S., Giovanelli, M., Benetti, A., Tiberio, G. A. et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann. Surg. 243, 229\u2013235 (2006).","journal-title":"Ann. Surg."},{"key":"1280_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/jnci\/djr027","volume":"103","author":"IL Wapnir","year":"2011","unstructured":"Wapnir, I. L., Dignam, J. J., Fisher, B., Mamounas, E. P., Anderson, S. J., Julian, T. B. et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J. Natl Cancer Inst. 103, 478\u2013488 (2011).","journal-title":"J. Natl Cancer Inst."},{"key":"1280_CR4","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","volume":"31","author":"M Donker","year":"2013","unstructured":"Donker, M., Litiere, S., Werutsky, G., Julien, J. P., Fentiman, I. S., Agresti, R. et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J. Clin. Oncol. 31, 4054\u20134059 (2013).","journal-title":"J. Clin. Oncol"},{"key":"1280_CR5","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","volume":"32","author":"F Warnberg","year":"2014","unstructured":"Warnberg, F., Garmo, H., Emdin, S., Hedberg, V., Adwall, L., Sandelin, K. et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J. Clin. Oncol. 32, 3613\u20133618 (2014).","journal-title":"J. Clin. Oncol."},{"key":"1280_CR6","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/bjc.2012.151","volume":"106","author":"MG Wallis","year":"2012","unstructured":"Wallis, M. G., Clements, K., Kearins, O., Ball, G., Macartney, J. & Lawrence, G. M. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer 106, 1611\u20131617 (2012).","journal-title":"Br J Cancer"},{"key":"1280_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/bjc.2012.41","volume":"106","author":"E Rakovitch","year":"2012","unstructured":"Rakovitch, E., Nofech-Mozes, S., Hanna, W., Narod, S., Thiruchelvam, D., Saskin, R. et al. HER2\/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. Br. J. Cancer 106, 1160\u20131165 (2012).","journal-title":"Br. J. Cancer"},{"key":"1280_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10549-020-05816-x","volume":"183","author":"EJ Groen","year":"2020","unstructured":"Groen, E. J., Hudecek, J., Mulder, L., van Seijen, M., Almekinders, M. M., Alexov, S. et al. Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study. Breast Cancer Res. Treat. 183, 759\u2013770 (2020).","journal-title":"Breast Cancer Res. Treat."},{"key":"1280_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","volume":"101","author":"AM Thompson","year":"2018","unstructured":"Thompson, A. M., Clements, K., Cheung, S., Pinder, S. E., Lawrence, G., Sawyer, E. et al. Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project. Eur. J. Cancer 101, 210\u2013219 (2018).","journal-title":"Eur. J. Cancer"},{"key":"1280_CR10","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","volume":"28","author":"U Rudloff","year":"2010","unstructured":"Rudloff, U., Jacks, L. M., Goldberg, J. I., Wynveen, C. A., Brogi, E., Patil, S. et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J. Clin. Oncol. 28, 3762\u20133769 (2010).","journal-title":"J. Clin. Oncol"},{"key":"1280_CR11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/ijc.32362","volume":"146","author":"MR Van Bockstal","year":"2020","unstructured":"Van Bockstal, M. R., Agahozo, M. C., Koppert, L. B. & van Deurzen, C. H. M. A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast. Int. J. Cancer 146, 1189\u20131197 (2020).","journal-title":"Int. J. Cancer"}],"updated-by":[{"DOI":"10.1038\/s41416-021-01520-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01280-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01280-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:13:28Z","timestamp":1649164408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-021-01280-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,4,12]]}},"alternative-id":["1280"],"URL":"https:\/\/doi.org\/10.1038\/s41416-021-01280-6","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41416-021-01520-9","URL":"https:\/\/doi.org\/10.1038\/s41416-021-01520-9","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"M.R. Van Bockstal received a postdoctoral mandate (grant number 2019-089) from the not-for-profit organisation Foundation against Cancer (Brussels, Belgium), and is supported by the \u201cFonds dr. Ga\u00ebtan Lagneaux\u201d of the Fondation Saint-Luc (Brussels, Belgium). C. Galant is supported by the \u201cFonds dr. Ga\u00ebtan Lagneaux\u201d of the Fondation Saint-Luc (Brussels, Belgium).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}